Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1 ) and receptor-5 (S1P5 ) agonist with autoimmune disease-modifying activity.
Scott FL, Clemons B, Brooks J, Brahmachary E, Powell R, Dedman H, Desale HG, Timony GA, Martinborough E, Rosen H, Roberts E, Boehm MF, Peach RJ. Scott FL, et al. Among authors: clemons b. Br J Pharmacol. 2016 Jun;173(11):1778-92. doi: 10.1111/bph.13476. Epub 2016 Apr 28. Br J Pharmacol. 2016. PMID: 26990079 Free PMC article.
Crystal structure of a lipid G protein-coupled receptor.
Hanson MA, Roth CB, Jo E, Griffith MT, Scott FL, Reinhart G, Desale H, Clemons B, Cahalan SM, Schuerer SC, Sanna MG, Han GW, Kuhn P, Rosen H, Stevens RC. Hanson MA, et al. Among authors: clemons b. Science. 2012 Feb 17;335(6070):851-5. doi: 10.1126/science.1215904. Science. 2012. PMID: 22344443 Free PMC article.
Actions of a picomolar short-acting S1P₁ agonist in S1P₁-eGFP knock-in mice.
Cahalan SM, Gonzalez-Cabrera PJ, Sarkisyan G, Nguyen N, Schaeffer MT, Huang L, Yeager A, Clemons B, Scott F, Rosen H. Cahalan SM, et al. Among authors: clemons b. Nat Chem Biol. 2011 May;7(5):254-6. doi: 10.1038/nchembio.547. Epub 2011 Mar 27. Nat Chem Biol. 2011. PMID: 21445057 Free PMC article.
Identification and characterization of novel small-molecule protease-activated receptor 2 agonists.
Gardell LR, Ma JN, Seitzberg JG, Knapp AE, Schiffer HH, Tabatabaei A, Davis CN, Owens M, Clemons B, Wong KK, Lund B, Nash NR, Gao Y, Lameh J, Schmelzer K, Olsson R, Burstein ES. Gardell LR, et al. Among authors: clemons b. J Pharmacol Exp Ther. 2008 Dec;327(3):799-808. doi: 10.1124/jpet.108.142570. Epub 2008 Sep 3. J Pharmacol Exp Ther. 2008. PMID: 18768780
Novel and potent small-molecule urotensin II receptor agonists.
Lehmann F, Currier EA, Clemons B, Hansen LK, Olsson R, Hacksell U, Luthman K. Lehmann F, et al. Among authors: clemons b. Bioorg Med Chem. 2009 Jul 1;17(13):4657-65. doi: 10.1016/j.bmc.2009.04.062. Epub 2009 May 3. Bioorg Med Chem. 2009. PMID: 19481466
Inhaled seralutinib exhibits potent efficacy in models of pulmonary arterial hypertension.
Galkin A, Sitapara R, Clemons B, Garcia E, Kennedy M, Guimond D, Carter LL, Douthitt A, Osterhout R, Gandjeva A, Slee D, Salter-Cid L, Tuder RM, Zisman LS. Galkin A, et al. Among authors: clemons b. Eur Respir J. 2022 Dec 1;60(6):2102356. doi: 10.1183/13993003.02356-2021. Print 2022 Dec. Eur Respir J. 2022. PMID: 35680144 Free PMC article.
Curriculum mapping of accredited pharmacy programs in the United States.
Talasaz AH, Donohoe KL, Van Tassell B; VCU Curriculum Investigators; Truong A, Shaunak A, Wayne A, Brenner A, Cherian B, Long B, Clemons B, Cason C, Hoang CC, Tran C, Dent D, Quinn E, Allegra AG, Price G, Sharp H, Nguyen H, Gomez J, Hodge J, Lai J, Everett J, Hunt J, Zhang J, Zhang J, Hsu J, Bowles K, Rowe K, Loch K, Han K, Reid K, So L, Noble M, Puryear M, Dance M, Bland M, LaPorte M, Lowe N, DiStefano N, Crawford P, Spence R, Fleku S, Henderson S, Viramgama S, Lee S, Yang S, Vickhouse S, Saunders S, Roussel S, Cuffee T, Huynh T, Olajide T, Yousufzai Y. Talasaz AH, et al. Among authors: clemons b. Curr Pharm Teach Learn. 2023 Jul;15(7):661-665. doi: 10.1016/j.cptl.2023.06.017. Epub 2023 Jun 29. Curr Pharm Teach Learn. 2023. PMID: 37391352
33 results